One of the things that investors need to keep in mind when it comes to the stock markets is to have an idea about the stocks which may have made significant moves in the recent past. However, it is also important to go through the latest developments and look into the gains made by the stock and any spikes in trading volumes in order to make an informed decision. This article is going to provide you with a quick look into four stocks that have big moves over the recent weeks and could now be worth tracking closely.

ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) – Last Friday the stock made a big move as it ended up with gains of 39.31% and closed at $4.04 a share. The trading volume had also gone up 46 times its 60-day average.

The company is a major innovator in the biotech space, having come up with its own artificial intelligence-powered LENS platform, which helps in crunching massive volumes of biological data with considerable accuracy and speed. The company could eventually end up licensing the product out to other industries too.

SusGlobal Energy Corp (OTC:SNRG) – The stock generated significant interest last Friday as it shot up by 50.17% to end the day at $0.375 a share. 654030 shares in the company were traded and the trading volume went up fourfold to its average 60-day volume.

The environmental, industrial, and agricultural biotech firm announced on April 25 that its fully owned subsidiary SusGlobal Energy Belleville Ltd had generated around 9500 Verified Emission Reductions and Removals. The subsidiary also managed to sell around 3000 of those credits to the Anew™ SusGlobal Belleville Composting Offset Project based in Ontario.

DarkPulse Inc (OTC:DPLS) – Since April 20, 2023, the stock has been in the middle of a remarkable rally and clocked gains of 187.5%. Last month on April 13, the company’s Chief Executive Officer Dennis O’Leary had gone to the Stock Day Podcast for an interview.

In the interview, he has spoken at length about the company’s aims and objectives as a laser-based monitoring system developer, which helps in rapid and accurate temperature monitoring. 

Enzolytics Inc (OTC:ENZC) – In the past 30 days, ENZC is another stock to have made substantial gains with a jump of 300%.

Recently, it was announced that its fully owned subsidiary unit Virogenetics was going to conduct a pilot clinical trial for its ITV-1 immunotherapy for diabetes at the Bulgarian National Center for Endocrinology. Virogenetics also bought a flow machine for the purpose of filling the single vials with its ITV-1 product.